Your browser doesn't support javascript.
loading
Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge.
De Monte, Anne; Courjon, Johan; Anty, Rodolphe; Cua, Eric; Naqvi, Alissa; Mondain, Véronique; Cottalorda, Jacqueline; Ollier, Laurence; Giordanengo, Valérie.
Afiliación
  • De Monte A; Department of Virology, Biological and Pathological Center, Centre Hospitalier Universitaire de Nice, France.
  • Courjon J; Department of Infectious Diseases, Centre Hospitalier Universitaire de Nice, France.
  • Anty R; Digestive Center, Centre Hospitalier Universitaire de Nice, France; Institut National de la Santé et de la Recherche Médicale (INSERM), U895, Team 8, Hepatic Complications in Obesity, France; University of Nice-Sophia-Antipolis, Faculty of Medicine, France.
  • Cua E; Department of Infectious Diseases, Centre Hospitalier Universitaire de Nice, France.
  • Naqvi A; Department of Infectious Diseases, Centre Hospitalier Universitaire de Nice, France.
  • Mondain V; Department of Infectious Diseases, Centre Hospitalier Universitaire de Nice, France.
  • Cottalorda J; Department of Virology, Biological and Pathological Center, Centre Hospitalier Universitaire de Nice, France.
  • Ollier L; Department of Virology, Biological and Pathological Center, Centre Hospitalier Universitaire de Nice, France. Electronic address: ollier.l@chu-nice.fr.
  • Giordanengo V; Department of Virology, Biological and Pathological Center, Centre Hospitalier Universitaire de Nice, France; University of Nice-Sophia-Antipolis, Faculty of Medicine, France; Institut National de la Santé et de la Recherche Médicale (INSERM), U1065, France.
J Clin Virol ; 78: 27-30, 2016 May.
Article en En | MEDLINE | ID: mdl-26967675
Use of direct-acting antiviral drugs (DAAs) greatly improves management of adults infected with hepatitis C virus (HCV) whether patients are treatment-naive or unsuccessfully pre-treated. Several inhibitors of viral nonstructural proteins (NS3/4A protease, NS5A and NS5B polymerase) allow a rapid HCV clearance and increase rates of sustained virological response. Both the EASL and AASLD guidelines have recently published up-to-date recommendations for their use, addressing each HCV genotype and particular situations. However, management of patients coinfected with hepatitis B virus (HBV) has been developed by these guidelines with reference to cases of HBV reactivation reported during previous anti-HCV regimens containing interferon known active against both HBV and HCV. In the setting of the interferon-free HCV therapies with DAAs only, the possibility of HBV reactivation during treatment of hepatitis C is raised due to viral interferences in HCV/HBV coinfected persons. Herein, we report a case of early HBV reactivation during DAAs-based anti-HCV treatment (ledipasvir/sofosbuvir) in a patient having a resolved HBV infection and chronically infected with HCV genotype 4 and HIV. Moreover, we review similar recent cases of HBV reactivation in patients infected with HBV and HCV genotype 1 during treatment of hepatitis C by regimen incorporating other combination of DAAs (sofosbuvir/simeprevir or daclatasvir/asunaprevir). Due to the potential risk of early HBV reactivation in HCV/HBV-coinfected patients during interferon-free DAAs-based HCV therapies, altogether these cases highlight the necessity to closely monitor HBV coinfection, regardless its stage (chronic, occult, resolved), whatever HCV genotype or class of DAAs used.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Inhibidores de Proteasas / Activación Viral / Virus de la Hepatitis B / Hepatitis B Crónica / Hepatitis C Crónica Tipo de estudio: Guideline Límite: Humans / Male / Middle aged Idioma: En Revista: J Clin Virol Asunto de la revista: VIROLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Inhibidores de Proteasas / Activación Viral / Virus de la Hepatitis B / Hepatitis B Crónica / Hepatitis C Crónica Tipo de estudio: Guideline Límite: Humans / Male / Middle aged Idioma: En Revista: J Clin Virol Asunto de la revista: VIROLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Países Bajos